Home > Financial Ratios > THYROCARE TECHNOLOGIES

THYROCARE TECHNOLOGIES
Core EBITDA Growth

    Back to All Ratios
THYROCARE TECHNOLOGIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for THYROCARE TECHNOLOGIES
Please provide your vote to see the results

THYROCARE TECHNOLOGIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 13.12-50.5844.251.919.78

What is the latest Core EBITDA Growth ratio of THYROCARE TECHNOLOGIES ?

The latest Core EBITDA Growth ratio of THYROCARE TECHNOLOGIES is 13.12 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202413.12
Mar2023-50.58
Mar202244.25
Mar20211.91
Mar20209.78

How is Core EBITDA Growth of THYROCARE TECHNOLOGIES Trending?

Years Core EBITDA Growth % Change
Mar2024 13.12
Positive
Mar2023 -50.58
Negative
Mar2022 44.25
2,216.75
Mar2021 1.91
-80.47
Mar2020 9.78 -

Other Financial Ratios of THYROCARE TECHNOLOGIES


Compare Core EBITDA Growth ratio of peers of THYROCARE TECHNOLOGIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
THYROCARE TECHNOLOGIES ₹4,149.4 Cr -0.3% -9.2% 34.4% Stock Analytics
MAX HEALTHCARE INSTITUTE ₹111,174.0 Cr -0.2% -0.5% 36.1% Stock Analytics
APOLLO HOSPITALS ENTERPRISE ₹97,577.3 Cr -0.2% -3.5% 11.2% Stock Analytics
FORTIS HEALTHCARE ₹49,049.6 Cr 4.7% -5.5% 43.9% Stock Analytics
GLOBAL HEALTH ₹31,356.2 Cr 11.7% 8.8% -5.6% Stock Analytics
NARAYANA HRUDAYALAYA ₹28,710.7 Cr 3.8% 7.1% 0.6% Stock Analytics


THYROCARE TECHNOLOGIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
THYROCARE TECHNOLOGIES

-0.3%

-9.2%

34.4%

SENSEX

0.5%

0.3%

7.9%


You may also like the below Video Courses